Background Previous studies have shown that investigation by tilt testing is very appropriate in paediatrics, but the characteristics of children and adolescents who are at high risk of recurrent syncope, once the diagnosis is established, remain unclear. This study was set up to analyse the risk factors attributed to syncope recurrence in paediatric patients.
Introduction
Syncope is a common clinical problem that occurs at all ages and is particularly prevalent in childhood and adolescence. Driscoll et al. [1] have reported an incidence of 125·8 per 100 000 children. Syncope was the chief complaint for 1% of all emergency admissions analysed by Pratt and Fleisher [2] . It is believed that at least 15% of all children will experience a syncopal episode before the end of the second decade [3] [4] [5] . Although frequently benign, recurrent syncope may be harmful, may lead to trauma or injury and may induce anxiety. With the exception of those few children and adolescents with a structural heart disease, the most likely aetiology is vasovagal. Previous works have shown that the head-up tilt test is a useful diagnostic tool in paediatrics [6] [7] [8] [9] [10] .
Although the head-up tilt test is increasingly used in the work-up of children and adolescents with syncope, it remains unclear who are at high risk of recurrent syncope.
In order to prevent syncope recurrence, a variety of treatments have been introduced, including betablockers, disopyramide, midodrine, fludrocortisone and salt or fluid supplements [11] [12] [13] [14] [15] . The therapeutic results, however, are unsatisfactory, with uncertainty remaining about how to select children who would benefit from preventive therapy. At present, the challenge involves the prediction of recurrence. In studies performed in adults, Sheldon et al. [16] and Grimm et al. [17] analysed risk factors for recurrent syncope after the head-up tilt test. Both authors found that risk was strongly predicted by the number of historical syncopal spells. To the best of our knowledge, only Salim et al. [18] previously reported the intermediate-term outcome of children presenting with syncope and its relation to the head-up tilt test.
This study was set up to examine the long-term follow-up of children and adolescents referred for the evaluation of syncope or pre-syncope, and to analyse risk factors for recurrent syncope.
Methods

Patients sample
Consecutive children and adolescents (n=101, 48 girls and 53 boys, age 12·6 3 years, range 7 to 18 years) were referred to our outpatient clinic because of recurrent syncope (n=91) or pre-syncope (n=10) and prospectively included in the study. Medical history, physical examination and standard non-invasive investigations, including the 12-lead electrocardiogram, were always non-diagnostic. In the majority, they were managed on an ambulatory basis. An echocardiogram, a 24-h Holter electrocardiogram, and neurological evaluation, performed at the discretion of the referring physician, were normal. The subjects had no evidence of underlying structural heart disease, long QT or Brugada syndrome, and none were on medication known to affect heart rate or to cause orthostatic hypotension. After completion of the standard aetiological work-up, the head-up tilt test was selected as the most appropriate with which to evaluate the children' symptoms.
Head-up tilt test protocol
Our protocol has been detailed previously [10, 19] . Briefly, children were tested in the absence of any active cardiovascular drug. Surface electrocardiographic leads I, II and III and finger arterial blood pressure using a finger cuff (2300 Finapress , Ohmeda, Englewood U.S.A.) were continuously monitored. Baseline measurements were obtained after 15 min of stabilization in the supine position. Children were then tilted upright to 60 for 45 min, and if no symptoms occurred after this passive phase, isoproterenol was administrated in escalating doses every 3 min ranging from 0·02 to 0·08 g . kg 1 for up to 15 min.
Diagnostic criteria and definitions
The head-up tilt test end-point was the induction of syncope, or pre-syncope, reproducing the children's clinical symptoms. Syncope was defined as a transient loss of consciousness, and pre-syncope as any of the various premonitory signs of an imminent syncope. A vasovagal response was considered when hypotension, or bradycardia, or both were observed [20] . Asystole was defined as a pause greater than 5 s [19] . Psychogenic syncope, as coined by Grubb et al. [21] , was considered when intense subjective fear, tremor, hyperventilation or sinus tachycardia (d120 beats . min 1 ), or other symptoms were not associated to any change in blood pressure.
The severity of symptoms was classified according to the frequency of syncope (d3 episodes per year), a shorter interval between two episodes (i.e. symptom duration divided by the number of episodes), the absence of prodromes, or the existence of serious trauma, injury or seizure during spontaneous episodes. Duration of symptoms refers to the number of months elapsed between the first historical syncopal spell and the diagnostic head-up tilt test.
Therapeutic trials
After a head-up tilt test, all children and their families underwent counselling about their diagnosis, morbidity and likelihood of survival after vasovagal syncope. Children with a positive head-up tilt test were reassured, counselled about recognizing their prodromes, and shown appropriate postural manoeuvres when presyncopal. Avoidance of salt depletion was recommended. Children considered to have severe symptoms were treated empirically and where therapeutic efficacy was uncertain, clarity was established.
In reference to the mechanisms currently believed to cause vasovagal syncope [22] , beta-blockers (when not contraindicated) were selected as the most appropriate preventive therapy. Oral fluid therapy, dysopiramide, or midodrine were considered in children in whom betablocker therapy was contraindicated or for those without sinus tachycardia preceding tilt-induced syncope. Earlier approaches (until 1993) involved the implantation of a permanent pacemaker in children with tiltinduced asystole [19] . This approach was later revised for first attempt beta-blocker therapy [23] . Psychogenic syncope warranted psychotherapy.
Follow-up
Before discharge, children were trained to record their symptoms and asked to notify our department after a Syncope in children and adolescents 1619 syncopal episode. Syncope recurrence was documented along with features as reported by the children, with bystander witnesses and by searching for signs of physical trauma such as abrasions or contusions. At the end of the follow-up period, children were interviewed either in the clinic or by telephone. The primary end-point measure was the recurrence of syncope, as it is straightforward. Recurrence of pre-syncope was not considered as an end-point.
As regards head-up tilt test results, children were subsequently classified into three follow-up groups: a first group with a positive head-up tilt test and preventive therapy (treated group), a second group with positive head-up tilt test but without preventive therapy (untreated group), and a third group with a negative head-up tilt test. Efficacy of empirical treatment was established in the absence of recurring syncope. Children presenting with induced asystole were submitted to a control head-up tilt test under therapy.
Statistical analysis
Statistical analysis was used to characterize children with positive and negative tilt responses, children with recurrence of syncope, children who had undergone preventive therapy and those who had not, and to determine factors predicting syncopal recurrence. Data are expressed as mean SD. The two-sided unpaired t-test was used to assess differences between groups. The Welch alternate t-test was used when variances were inhomogenous. Contingency tables were analysed using the Fisher's exact test. Linear regression was performed when appropriate. The two-tailed P value c0·05 was considered statistically significant.
Results
Demographic
Between 1990 and 1998, 101 consecutive children and adolescents were included in the present study. Table 1 summarizes the main clinical characteristics of the study population. They had had a geometric mean of four syncopal spells over a mean of 26 months. Figure 1 illustrates the distribution of the 91 children who had experienced syncope, according to their historical number of syncope. Although the majority of these children (53 of 91) had c3 spells, there was a substantial population (13 of 91) with d10 spells.
Tilt test result
The head-up tilt test was positive in 67 patients, during its passive phase in 47 children after a mean delay of 28 16 min, and during isoproterenol infusion in the remaining 20 children. Positive responses included 58 vasovagal syncope or pre-syncope (20 mixed responses, 28 vasodepressor responses, 10 asystole of 11 3 s mean duration), and nine psychogenic syncope or presyncope. The vasovagal response occurred predominantly during the passive phase of the head-up tilt test (77%), while the psychogenic response was elicited during isoproterenol infusion (78%). In 14 cases (21%), the induced syncope were associated with seizure. This was most notable in nine of the 10 children presenting with asystole.
There were no differences between children with positive and negative head-up tilt test results, with respect to age, gender distribution, number of syncopal episodes, duration of symptoms and occurrence of trauma or injuries, or seizures during spontaneous syncopal episodes (Table 2) .
Medication used during the study
Following the head-up tilt test, 43 of 67 children with a positive head-up tilt test received empiric preventive therapy, which was beta-blockers in 24 children (of which five had an asystolic response), disopyramide in two children, oral fluid therapy in two children, midodrine in three children, psychogenic therapy in eight children and dual-chamber pacemaker for four children with an asystolic response. After the first recurrence of syncope, six children (five with beta-blockers and one with midodrine) had a change in their treatment. The remaining 24 children with a positive head-up tilt test (including one with asystole) and none of the 34 with a negative head-up tilt test were treated, as the reported severity or awareness of premonitory symptoms would not warrant medication.
A surprising observation is that all clinical characteristics and head-up tilt test data acquired from the 43 treated positive head-up tilt test children closely resemble the characteristics of the 24 untreated patients (Table 3) , as well as those of the 34 children with a negative head-up tilt test response.
Clinical follow-up
Data were available on 66 positive head-up tilt test children and 31 negative head-up tilt test children, with four children lost. After a mean follow-up of 46 28 months (range 7 to 104 months), 32% of patients (31/97) had one to 20 (mean 6 7) syncopal spells after head-up tilt test, whereas 68% (66/97) did not present with a recurrent syncope.
The relationship between syncope recurrence and head-up tilt test results were compared. Of note, the incidence of recurrence was the same regardless of 
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whether the patients had a positive or a negative head-up tilt test response, as shown in Fig. 2 . Similarly, when this relationship was assessed in treated and untreated patients (Fig. 3) , no influence of prophylactic therapy on the rate of syncope recurrence was evident.
To determine whether the risk of syncope in each patient changed over time, we assessed the relationship between the number of recurrent syncopal spells and the number of syncope preceding tilt testing. A significant correlation between the two values was found, both in the total cohort (r=0·6, 95% CI 0·47 to 0·72, P<0·0001) (Fig. 4(a) ), and amongst treated children (r=0·5, 95% CI 0·29 to 0·73, P=0·0001) (Fig. 4(b) ). Indeed when compared in a univariate analysis as illustrated in Table 4 , children with a recurrence of syncope had more prehead-up tilt test syncopal spells (7 8 vs 3 3, P=0·01) than those without, while the other clinical variables were not predictive of recurrence. The same relationship was observed when the subgroups of untreated children with a positive and negative head-up tilt test were analysed (Fig. 4(c) and (d), respectively) . The relationship between the number of recurrent syncopal spells and the number of historical syncope, however, tended to be stronger in the positive head-up tilt test untreated group compared to the positive head-up tilt test treated one.
Similar results were again observed (r=0·6, 95% CI 0·37 to 0·79, P<0·0001) when analysis was restricted to the treated subgroup in whom tilt testing elicited a vasovagal reaction (i.e. after withdrawal of children with a psychogenic syncope).
The recurrence rate was also assessed between children with vasovagal and psychogenic syncope, and the subgroup with an asystolic response. In patients with psychogenic syncope, the recurrence rate tended to be greater than in those with VVS, although, the difference was not statistically significant (Table 4) . No syncope recurred in children with asystole.
Discussion
Although the head-up tilt test is being increasingly used in the work-up of syncope in paediatrics, it remains unclear which children are at high risk of recurrent syncope when neurally mediated syncope has been diagnosed. It also remains unclear which children may benefit from preventive therapy [24] . During a mean follow-up of 4 years, this study examined the incidence of syncope recurrence in medically treated and untreated children and adolescents referred for the evaluation of recurrent syncope. These findings demonstrated that the only predictor of longterm outcome in paediatrics is the total number of spells documented at admission, and also showed that the risk of syncope recurrence is not influenced by head-up tilt test results or preventive therapy.
Clinical implications
In adults suffering from VVS, the vast majority of series analysing recurrences have shown a recurrence rate of about 30% during a 2-year follow-up after a positive head-up tilt test and in the absence of any medication [25] . Sheldon et al. [16] , analysing risk factors for recurrent syncope in 101 medically untreated adults aged 36 19 years, presenting with syncope and a positive head-up tilt test, observed that the most powerful predictor of syncope recurrence was the total number of historical syncopal spells, with another predictive variable being the duration of syncope episodes. Grimm et al. [17] prospectively followed-up 80 untreated patients aged 40 16 years over 23 8 months with suspected vasovagal syncope. These displayed a 33% syncope recurrence, the data agreeing with Sheldon's 28%. Neither studies administrated preventive therapy and both observed that recurrence was better predicted by the number of historical syncope. Head-up tilt test results were not found to be useful as a predictive tool. Our results agree with these conclusions.
Although syncope is even more prevalent in children and adolescents, data analysing risk factors of syncope recurrence in a paediatric population is scarce. To the 
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best of our knowledge, there is only one study, published by Salim et al. [18] , which examined the intermediate-term outcome of 45 children with syncope and its relationship to the head-up tilt test. Their results are similar to those concluded here: children with recurrent syncope reported more episodes before the evaluation than the group with no recurrent syncope. In contrast to our results, however, Salim et al. found that the rate of recurrent syncope was higher in children with a positive head-up tilt test, 52% vs 13% for the negative head-up tilt test group. The duration of follow-up may, in part, explain the difference between our results and those of Salim et al. [18] . Indeed, as far as we know, no previous report, assessing a 4-year follow-up study concerned with clinical outcome in paediatrics, has been published.
A clearer appreciation of premonitory symptoms may lead the majority of children to an earlier recognition of the ensuing syncope, perhaps helping them with preventive measures, such as assuming a sitting or supine position. Indeed, with such measures, Sheldon et al. [16] observed a significant decrease in the incidence of syncopal episodes from a median rate of three episodes per month before the head-up tilt test to 0·3 episodes per month after a positive head-up tilt test. In the experience of Moya et al. [26] , the syncopal incidence dropped by a significant 50% after the head-up tilt test. Relief from anxiety, after clear reassurance, may play a role.
In fact, recognition of the aetiology and reassurance of good prognosis in the follow-up can help to reduce patients' anxiety and consequently have a favourable impact on severity. It is then important to point out in clinical practice that because the real effectiveness of preventive therapy has not yet been fully established in neurally-mediated syncope and since the majority of children will remain free of recurrent syncope without medical therapy, only those with a long-standing history of frequent syncope may benefit from preventive treatment. Indeed, even if the rate of recurrence has been the same in treated and untreated positive-head-up tilt test children in our study, linear correlation revealed a stronger relationship between the number of recurrent syncope and the number of historical syncope in untreated positive-head-up tilt test children, suggesting that the impact of preventive medical or psychological therapy was beneficial in the subsequent outcome of selected children with a long-standing history of frequent syncopal spells.
Limitations
Follow-up studies are critically dependent on the choice of end-point, which include recurrences of syncope and/or pre-syncope. We chose to use syncope as a primary end-point because it is easily quantifiable. Presyncope was not chosen due to anticipated difficulties with quantifying its variable severity and duration, despite the fact that recurrent pre-syncope is likely to be a significant problem in the lives of children with syncope.
Treatment was not randomized, as the study was designed on an intent-to-treat basis, with limitations inherent to this approach. This, however, did not appear to affect our primary end-point, which was to look at the risk factors of syncope recurrence in children with recurrent syncope of a presumed vasovagal origin.
Conclusions
Our study showed no correlation between tilt test results or preventive therapy and the likelihood of recurring syncope. It found, however, that the only predictive factor for recurrence in paediatric patients was the number of historical syncopal spells. Treatment should be proposed to children severely affected by numerous syncopes.
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